264 related articles for article (PubMed ID: 38643164)
1. A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironments.
Zhang Y; Hu Q; Pei Y; Luo H; Wang Z; Xu X; Zhang Q; Dai J; Wang Q; Fan Z; Fang Y; Ye M; Li B; Chen M; Xue Q; Zheng Q; Zhang S; Huang M; Zhang T; Gu J; Xiong Z
Nat Commun; 2024 Apr; 15(1):3382. PubMed ID: 38643164
[TBL] [Abstract][Full Text] [Related]
2. Organoids: approaches and utility in cancer research.
Zhou B; Feng Z; Xu J; Xie J
Chin Med J (Engl); 2023 Aug; 136(15):1783-1793. PubMed ID: 37365679
[TBL] [Abstract][Full Text] [Related]
3. Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine.
Qu S; Xu R; Yi G; Li Z; Zhang H; Qi S; Huang G
Mol Biomed; 2024 Feb; 5(1):6. PubMed ID: 38342791
[TBL] [Abstract][Full Text] [Related]
4. Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer.
Chen Y; Liu Y; Chen S; Zhang L; Rao J; Lu X; Ma Y
Front Immunol; 2023; 14():1180184. PubMed ID: 37334366
[TBL] [Abstract][Full Text] [Related]
5. Reconstructing the tumor architecture into organoids.
Luo Z; Zhou X; Mandal K; He N; Wennerberg W; Qu M; Jiang X; Sun W; Khademhosseini A
Adv Drug Deliv Rev; 2021 Sep; 176():113839. PubMed ID: 34153370
[TBL] [Abstract][Full Text] [Related]
6. An Automated Organoid Platform with Inter-organoid Homogeneity and Inter-patient Heterogeneity.
Jiang S; Zhao H; Zhang W; Wang J; Liu Y; Cao Y; Zheng H; Hu Z; Wang S; Zhu Y; Wang W; Cui S; Lobie PE; Huang L; Ma S
Cell Rep Med; 2020 Dec; 1(9):100161. PubMed ID: 33377132
[TBL] [Abstract][Full Text] [Related]
7. Unlocking the potential of organoids in cancer treatment and translational research: An application of cytologic techniques.
Abd El-Salam MA; Troulis MJ; Pan CX; Rao RA
Cancer Cytopathol; 2024 Feb; 132(2):96-102. PubMed ID: 37843532
[TBL] [Abstract][Full Text] [Related]
8. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
[TBL] [Abstract][Full Text] [Related]
9. [Application and Research Progress of Lung Cancer Organoid in Precision Medicine
for Lung Cancer].
Huang Z; Li B; Wang Y; Xue J; Wei Z; Liang N; Li S
Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):276-282. PubMed ID: 38769830
[TBL] [Abstract][Full Text] [Related]
10. Tumour organoids and assembloids: Patient-derived cancer avatars for immunotherapy.
Mei J; Liu X; Tian HX; Chen Y; Cao Y; Zeng J; Liu YC; Chen Y; Gao Y; Yin JY; Wang PY
Clin Transl Med; 2024 Apr; 14(4):e1656. PubMed ID: 38664597
[TBL] [Abstract][Full Text] [Related]
11. Tumor organoids: applications in cancer modeling and potentials in precision medicine.
Xu H; Jiao D; Liu A; Wu K
J Hematol Oncol; 2022 May; 15(1):58. PubMed ID: 35551634
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine.
Taverna JA; Hung CN; Williams M; Williams R; Chen M; Kamali S; Sambandam V; Hsiang-Ling Chiu C; Osmulski PA; Gaczynska ME; DeArmond DT; Gaspard C; Mancini M; Kusi M; Pandya AN; Song L; Jin L; Schiavini P; Chen CL
Lung Cancer; 2024 Apr; 190():107533. PubMed ID: 38520909
[TBL] [Abstract][Full Text] [Related]
13. Organoids: An intermediate modeling platform in precision oncology.
Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
[TBL] [Abstract][Full Text] [Related]
14. Emerging organoid models: leaping forward in cancer research.
Fan H; Demirci U; Chen P
J Hematol Oncol; 2019 Dec; 12(1):142. PubMed ID: 31884964
[TBL] [Abstract][Full Text] [Related]
15. Patient-derived organoids as a model for tumor research.
Wang J; Feng X; Li Z; Chen Y; Huang W
Prog Mol Biol Transl Sci; 2022; 189(1):259-326. PubMed ID: 35595351
[TBL] [Abstract][Full Text] [Related]
16. Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine.
Dijkstra KK; Monkhorst K; Schipper LJ; Hartemink KJ; Smit EF; Kaing S; de Groot R; Wolkers MC; Clevers H; Cuppen E; Voest EE
Cell Rep; 2020 May; 31(5):107588. PubMed ID: 32375033
[TBL] [Abstract][Full Text] [Related]
17. Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening.
Kim M; Mun H; Sung CO; Cho EJ; Jeon HJ; Chun SM; Jung DJ; Shin TH; Jeong GS; Kim DK; Choi EK; Jeong SY; Taylor AM; Jain S; Meyerson M; Jang SJ
Nat Commun; 2019 Sep; 10(1):3991. PubMed ID: 31488816
[TBL] [Abstract][Full Text] [Related]
18. Applications of lung cancer organoids in precision medicine: from bench to bedside.
Li H; Chen Z; Chen N; Fan Y; Xu Y; Xu X
Cell Commun Signal; 2023 Dec; 21(1):350. PubMed ID: 38057851
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer organoids, a promising model still with long way to go.
Ma HC; Zhu YJ; Zhou R; Yu YY; Xiao ZZ; Zhang HB
Crit Rev Oncol Hematol; 2022 Mar; 171():103610. PubMed ID: 35114386
[TBL] [Abstract][Full Text] [Related]
20. [Application of Organoids in Lung Cancer Precision Medicine].
Jia Z; Liang N; Li S
Zhongguo Fei Ai Za Zhi; 2020 Jul; 23(7):615-620. PubMed ID: 32702796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
